57
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22814 |
GSA-10
|
Hedgehog/Smoothened | GPCR/G Protein; Stem Cells |
GSA-10是新型的喹啉甲酰胺衍生物,有效激动平滑受体剂,EC50为 1.2 μM。它作用于Smo,促进多能间充质干细胞分化为成骨细胞。它介导 Hedgehog 信号传导,这可能对癌症疾病的再生医学具有研究意义。 | |||
T11438 |
GNE-1858
|
Others; MAPK | MAPK; Others |
GNE-1858 是高效的 ATP 竞争性造血祖细胞激酶-1抑制剂,能够抑制野生型(IC50:1.9 nM)、活性模拟突变株 HPK1-TSEE (IC50:1.9 nM)、 HPK1-SA (IC50:4.5 nM)的活性。 | |||
T0084 |
Moclobemide
吗氯贝胺,Ro111163 |
MAO; Monoamine Oxidase | Metabolism; Neuroscience |
Moclobemide (Ro111163) 是可逆的、可透过血脑屏障的单胺氧化酶 (MAO-A) 抑制剂,能够抑制 hMAO-A (IC50=6.061 μM)。它上调慢性应激小鼠海马祖细胞的增殖。 | |||
T8005 |
Cardiogenol C hydrochloride
2-[[2-[(4-甲氧基苯基)氨基]-4-嘧啶基]氨基]乙醇盐酸盐,Cardiogenol C HCl,Cardiogenol C |
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
Cardiogenol C hydrochloride (Cardiogenol C) 是一种细胞渗透性嘧啶诱导剂,能够促使 ESCs 分化为心肌细胞。在有限的可塑性范围内,它可以对已经沿袭的祖细胞类型产生心肌生成效应,是一种心肌生成试剂,在动物模型中可以用作细胞移植研究中提高心脏修复的工具。 | |||
T2161 |
Cardiogenol C
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
Cardiogenol C 是一种细胞渗透性嘧啶诱导剂,能够诱导 ESCs 分化为心肌细胞(EC50:100 nM)。在有限的可塑性范围内,它可以对已经沿袭的祖细胞类型产生心肌病,是一种心肌发生剂。 | |||
T16288 |
Neuropathiazol
|
Others | Others |
Neuropathiazol 引起成年海马神经祖细胞的神经元分化。 | |||
T63918 |
α-Tocopherol phosphate disodium
TocP disodium,Vitamin E phosphate disodium |
Apoptosis; Antioxidant; Reactive Oxygen Species | Apoptosis; Immunology/Inflammation; Metabolism; NF-κB; oxidation-reduction |
α-Tocopherol phosphate (alpha-Tocopherol phosphate) 是一种抗氧化剂,能够清除 UVA1 诱导的活性氧 (ROS) 并保护长波 UVA1 诱导的细胞死亡。α-Tocopherol phosphate disodium (Vitamin E phosphate disodium) 可阻碍内皮祖细胞凋亡 (apoptosis),增强高糖/低氧条件下内皮祖细胞迁移能力,促进血管生成。 | |||
T38287 |
C3a Receptor Agonist
C3a receptor agonist 1,C3a受体激动剂,Complement 3a Receptor Agonist |
Complement System | Immunology/Inflammation |
C3a Receptor Agonist (C3a receptor agonist 1) 结合免疫系统补体途径中的G 蛋白偶联C3a 受体(C3aRs)。在肠缺血再灌注损伤模型中,C3aR 的激活可防止中性粒细胞动员。C3aRs 在成年小鼠的神经祖细胞和未成熟神经元上表达。C3a 在体外刺激神经祖细胞的分化。 | |||
T1870 |
Y-27632
|
ROCK; Apoptosis | Apoptosis; Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Y-27632 是一种 ROCK-I 和 ROCK-II 抑制剂,具有口服有效性、ATP 竞争性。Y-27632 还抑制分离诱导的小鼠前列腺干或祖细胞凋亡。 | |||
T1725 |
Y-27632 dihydrochloride
反式-4-[(R)-1-氨基乙基]-N-(4-吡啶基)环己烷甲酰胺二盐酸盐,Y-27632 2HCl |
ROCK; Apoptosis | Apoptosis; Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
Y-27632 dihydrochloride (Y-27632 2HCl) 是一种 ROCK-I 和 ROCK-II 抑制剂,具有口服有效性、ATP 竞争性。Y-27632 dihydrochloride 还抑制分离诱导的小鼠前列腺干或祖细胞凋亡。 | |||
TP1474 |
LXW7
|
Integrin | Cytoskeletal Signaling |
LXW7 是一种整合素αvβ3抑制剂,是含 Arg-Gly-Asp (RGD) 的环状肽,对αvβ3整联蛋白具有很高的结合亲和力,IC50为 0.68 μM。它可增强 VEGFR-2 磷酸化和 ERK1/2 活化,具有抗炎活性。 | |||
T3980 |
Su1498
Tyrphostin SU 1498,AG 1498 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Su1498 (Tyrphostin SU 1498) 是一种选择性的 VEGFR2 抑制剂,能够抑制 Flk-1 (IC50:700 nM)。 | |||
T9017 |
HPK1-IN-2
Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2,HPK1-IN-2 |
Others; FLT; Src | Angiogenesis; Others; Tyrosine Kinase/Adaptors |
HPK1-IN-2 (Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2) 是一种有效且具有口服活性的造血祖细胞激酶-1 抑制剂(HPK1;IC50<0.05 µM)。它还抑制 Lck (0.05 µM<IC50<0.5 µM) 和 Flt3 (IC50<0.05 µM) 激酶活性,具有抗肿瘤活性。 | |||
T28866 |
Stemazole
|
Apoptosis | Apoptosis |
Stemazole 是一种新型小分子人类干/祖细胞增殖激活剂 ,可促进人类胚胎干细胞的存活并保持干性 ,促进少突胶质细胞前体细胞在体外的存活。Stemazole 能显著提高细胞存活率和克隆形成数,并呈剂量依赖性,降低细胞凋亡率,促进运动功能障碍的恢复和髓鞘的修复。Stemazole 可作为脱髓鞘疾病的治疗剂,促进OPC 体外存活和体内再生。 | |||
T21493 |
Cyclosporin H
|
Others | Others |
Cyclosporin H 是一种 FPR-1(甲酰肽受体 1) 的选择性强效抑制剂。它缺乏 Cyclosporin A 具有的免疫抑制活性。它是一种病毒转导增强剂,可使人脐带血来源的造血干细胞和祖细胞中慢病毒转导增强 10 倍。它与雷帕霉素或前列腺素 E2 联合使用时表现出累加效应。 | |||
T39709 |
HPK1-IN-19
HPK1-IN-19 |
||
HPK1-IN-19 is an inhibitor of hematopoietic progenitor kinase 1 (HPK1). | |||
T40188 |
HPK1-IN-20
HPK1-IN-20 |
||
HPK1-IN-19 is a potent inhibitor of hematopoietic progenitor kinase 1 (HPK1). | |||
T71256 |
Eilatine
|
||
Eilatine is a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients. | |||
T71793 |
CDMG1
|
||
CDMG1 is a novel Wnt inhibitor, promoting heart regeneration, injury repair, and myocardial hyperplasia through expansion of the cardiac progenitor cell population | |||
T27591 |
II-B08
II-B 08,FAP1 Inhibitor,II-B-08,LMWPTP Inhibitor,Lyp Inhibitor III,CD45 Inhibitor V |
||
II-B08 is a cell-permeable SHP2 inhibitor (IC50 = 5.5 µM). II-B08 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation. | |||
T72052 |
HPK1-IN-34
|
||
HPK1-IN-34是一种造血祖细胞激酶1(HPK1)抑制剂,IC50<100nM。 | |||
T72036 |
HPK1-IN-36
|
Others | Others |
HPK1-IN-36(compound 2)作为一种HPK1抑制剂,表现出高效性,其IC50为0.5 nM。 | |||
T68863 | MK-0626 free base | ||
MK-0626 is a Dipeptidyl peptidase IV (DPP-4) inhibitor, improving neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression. | |||
T33267 |
Me6TREN 4HCl
Me6TREN Tetrahydrochloride,Me6-TREN Tetrahydrochloride,Me6 4HCl,Me 6 4HCl,Me-6 4HCl |
||
Me6TREN 4HCl is a potent and efficacious mobilizing agent of hematopoietic stem and progenitor cells (HSPCs) that can act by activating MMP-9 expression and disrupting the SDF-1α/CXCR4 axis, exhibiting more significant mobilizing effects than G-CSF or AMD | |||
T70062 |
Osteoprotegerin
|
||
Osteoprotegerin is a soluble secreted member of the tumor necrosis factor receptor superfamily, inhibiting osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, leading to excess accumulation of bone and cartilage. | |||
TP2141L |
Balixafortide
POL6326 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM and it is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2]. Balixafortide blocks β-arresti | |||
T63046 |
HPK1-IN-15
|
||
HPK1-IN-15 是一种选择性的、有效的 HPK1 抑制剂。其中从造血祖细胞克隆的造血祖细胞激酶1 (HPK1) 属于 MAP4Ks 家族。HPK1-IN-15 能够用于与 HPK1 活性相关的疾病或病症 (如癌症) 的研究、预防或改善。 | |||
T62547 |
HPK1-IN-17
|
||
HPK1-IN-17 是一种选择性的、有效的 HPK1 抑制剂。造血祖细胞激酶1 (HPK1) 是 MAP4Ks 的家族成员,从造血祖细胞克隆。HPK1-IN-17 能够用于研究、预防或改善与 HPK1 活性相关的疾病或病症(如癌症)。 | |||
T61554 | CSF1R-IN-13 | ||
CSF1R-IN-13 is a powerful CSF1R inhibitor with potential applications in researching cancer diseases [1]. CSF1R, also known as colony stimulating factor 1 receptor, is a critical growth factor that regulates various cell types, including bone marrow progenitor cells, monocytes, macrophages, and giants [1]. CSF1R-IN-13 shows promise in furthering our understanding of cancer-related disorders (WO2019134661A1, compound 32) [1]. | |||
T38793 |
THI0019
THI0019 |
||
THI0019 is a highly potent agonist of the integrin α4β1 (VLA-4) receptor, with an EC 50 range of 1-2 μM. It effectively promotes the adhesion of stem/progenitor cells. Furthermore, THI0019 successfully modulates adhesion processes mediated by α4β7, α5β1, and αLβ2 integrins. | |||
T4310L2 |
Prexasertib mesylate
LY-2606368,LY2606368,LY 2606368 |
||
Prexasertib is a potent and selective Chk1/Chk2 inhibitor. Prexasertib increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. LY2606368 causes replication catastrophe and antitumor effects through CHK1-d | |||
T60973 |
HPK1-IN-24
|
||
HPK1-IN-24 (example 51) 可用于癌症领域研究,它是造血祖细胞激酶 1 (HPK1)的抑制剂 (Ki = 100 nM)。 | |||
T78852 |
HPK1-IN-39
|
||
HPK1-IN-39(Compound 10n)为一选择性HPK1抑制剂,IC50值为29 nM。该化合物能抑制SLP76磷酸化,可用于癌症免疫治疗研究。 | |||
T77992 |
Goralatide TFA
|
||
Goralatide TFA为细胞周期进程的抑制剂,能够增强热清除人祖细胞的选择性,表现出在白血病研究中的应用潜力。 | |||
T61449 | HPK1-IN-18 | ||
HPK1-IN-18 is a highly effective and specific HPK1 inhibitor. HPK1, a MAP kinase kinase kinase kinases (MAP4K) member, was initially isolated from hematopoietic progenitor cells. This compound, known as HPK1-IN-18, is valuable for investigating, preventing, or managing diseases or conditions linked to HPK1 activity, such as cancer[1]. | |||
T61733 |
HPK1-IN-25
|
||
HPK1-IN-25 (示例 94) 为一种造血祖细胞激酶1 (HPK1) 抑制剂,具有129 nM的IC50值,展现出在癌症研究中的潜力。 | |||
T81585 |
Oxyntomodulin (human, mouse, rat)
Proglucagon (33-69) |
||
Oxyntomodulin (human, mouse, rat) (Proglucagon (33-69)) 是由胰高血糖素前体产生,融合了完整胰高血糖素序列和C端八肽,含37个氨基酸。 | |||
T63541 |
HPK1-IN-27
|
||
HPK1-IN-27 是 HPK1 的有效抑制剂。其中 MAP4K1 也叫造血祖细胞激酶 1 (HPK1),是一种生发中心激酶家族的成员,是一种丝氨酸/苏氨酸激酶。HPK1-IN-27 对癌症疾病表现出研究潜力。 | |||
T64110 |
Debio 0617B
|
||
Debio 0617B 是一种多激酶抑制剂,能够降低原代人 AML CD34+干/祖细胞的维持和自我更新。Debio 0617B 靶向 STAT3/STAT5 信号上游关键激酶,如 JAK、ABL、SRC 和 III/V 类受体酪氨酸激酶。Debio 0617B 能够用于研究 STAT3 驱动的实体瘤。 | |||
T63659 | HPK1-IN-10 | ||
HPK1-IN-10 是 HPK1 的有效抑制剂。HPK1 是一种丝氨酸/苏氨酸蛋白激酶,由造血祖细胞克隆得到,是哺乳动物Ste-20相关蛋白激酶MAP4K 家族成员之一。HPK1-IN-10 对HPK1 相关疾病具有研究潜力。 | |||
T63287 | HPK1-IN-3 | ||
HPK1-IN-3 是一种选择性的、有效的、ATP 竞争性的造血祖细胞激酶 1 (HPK1; MAP4K1) 抑制剂 (IC50: 0.25 nM)。HPK1-IN-3 具有 IL-2 细胞效力,能够作用于人外周血单核细胞 (PBMC),EC50 值为 108 nM。 | |||
T63670 |
HPK1-IN-9
|
||
HPK1-IN-9 是一种有效的 HPK1 抑制剂。其中 HPK1 是一种丝氨酸/苏氨酸蛋白激酶,由造血祖细胞克隆得到,是哺乳动物Ste-20相关蛋白激酶MAP4K 家族成员之一。HPK1-IN-10 对HPK1 相关疾病具有研究潜力。 | |||
T73149 | HPK1-IN-33 | ||
HPK1-IN-33(化合物21)是造血祖细胞激酶1(HPK1)的高效抑制剂,其Ki值为1.7 µM。此化合物在Jurkat WT细胞中抑制IL-2产生的EC50为286 nM,而在Jurkat HPK1 KO细胞中的EC50则大于10000 nM。 | |||
T77172 | Eflapegrastim | ||
Eflapegrastim 是一种人源化IgG4单抗 ,也是一种粒细胞集落刺激因子 (G-CSF)。Eflapegrastim 靶向G-CSF 受体 (c-Fms)。Eflapegrastim 刺激中性粒细胞祖细胞的增殖和分化,维持成熟和功能性中性粒细胞数目稳定。Eflapegrastim 还缩短中性粒细胞减少的持续时间。 | |||
T63270 |
HPK1-IN-29
|
||
HPK1-IN-29 是 HPK1 有效的抑制剂,其中造血祖细胞激酶 1 (HPK1) 是一种树突状细胞 (DC)、T 细胞和 B 细胞活化反应的负调节剂。HPK1-IN-29 能够提高人体的抗肿瘤免疫力,表现出研究免疫相关疾病,尤其是肿瘤的潜力。 | |||
T70174 |
Pirlindole-d4 HCl
|
||
Pirlindole-d4 is intended for use as an internal standard for the quantification of pirlindole by GC- or LC-MS. Pirlindole is a selective and reversible monoamine oxidase A (MAO-A) inhibitor. It is selective for MAO-A over MAO-B. In rats, it reverses the depressive-like effects induced by chronic mild stress (CMS), increases proliferation of hippocampal neural progenitor cells, and reverses dendritic atrophy in granule neurons. Pirlindole is also an inhibitor of enterovirus-D68 and coxsackieviru... | |||
T76880 | Tepoditamab | ||
Tepoditamab (MCLA-117) 是一种双特异性的单克隆抗体,可以与骨髓细胞的 CLEC12A 和细胞毒性 T 细胞的 CD3结合。其中,CLEC12A 是一种骨髓分化抗原。Tepoditamab (MCLA-117) 可以杀死 AML 白血病母细胞和 AML 白血病干细胞,诱导 T 细胞介导的急性髓细胞增殖裂解,可用于急性骨髓性白血病(AML)研究。 | |||
T81154 | SIRT1 activator 1 | Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
SIRT1 activator1(compound 3),作为海洋化合物xyloallenoide a的衍生物,最初从红树林真菌Xylaria sp中分离获得。该化合物在斑马鱼模型中展现了促进血管生成的活性,并且能够通过提升SIRT1的表达水平以及调节AMPK/Akt信号通路,来防护人类内皮祖细胞(hEPC)免受血管老化的影响。 | |||
T37669 |
CAY10498
|
||
The A1, A2A, A2B, and A3 adenosine receptors (ARs) are ubiquitous G protein-coupled receptors. The four AR subtypes have been implicated in several areas of therapeutic interest such as stroke and other ischemic conditions, as well as inflammation, neurodegenerative diseases, diabetes, and sleep regulation. A3 AR antagonists are of interest as therapeutic agents in glaucoma agents and inflammation. CAY10498 is a potent and selective A3 AR antagonist exhibiting a Ki of 37 nM with 60 and 200-fold ... | |||
TP1354 |
ATI-2341 TFA (1337878-62-2 free base)
ATI-2341 TFA |
||
ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G p |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T64353 |
4-tert-Octylphenol
|
Endogenous Metabolite | Metabolism |
4-tert-Octylphenol 是一种干扰内分泌的化学物质及雌激素药物,能诱导子代小鼠脑神经元祖细胞的凋亡,并通过减少溴脱氧尿苷(BrdU)、有丝分裂标志物Ki67以及磷酸组蛋白H3(p-Histone-H3)的表达,导致神经元祖细胞的增殖减少。这种物质不仅会干扰小鼠的大脑发育,还会影响其行为。 | |||
T38429 |
(+)-Intermedine
|
||
(+)-Intermedine, a pyrrolizidine alkaloid (PA), shows remarkable cytotoxic activity against neural progenitor cells (NPCs). | |||
TN2147 |
Retrorsine
|
P450; OCT | Membrane transporter/Ion channel; Metabolism |
Retrorsine 特异性地抑制肝细胞增殖,并在肝损伤后唤起小肝细胞样祖细胞。逆转录酶可用于肝细胞损伤的研究。 |